Bovivac S Suspension for Injection for Cattle 50ml

Target Species Cattle. Indications for use For the active immunisation of cattle in order to induce serological and colostral antibody production against Salmonella dublin and Salmonella typhimurium and in the face of an outbreak to reduce Salmonella typhimurium infections when used under field conditions as part of an overall herd management programme. Bovilis Bovivac S may also contribute to reducing S. typhimurium contamination of the environment. Specific experimental data to quantify the duration of immunity or the degree of protection from colostral antibodies has not been generated. Significant levels of immunity cannot be expected until two weeks after the second dose of the primary vaccination course. Contraindications None. Special warnings for each target species None. Special precautions for use All stock showing overt clinical signs of salmonellosis at the time of the initial vaccination programme should receive appropriate treatment and be fully vaccinated once they have recovered. Any unvaccinated stock must be managed separately to vaccinated stock, with no contact between the groups. Hygiene precautions must be instituted, where possible, to prevent transfer of infection from one group to another. All animals of a herd should be vaccinated. The effect of maternally derived antibodies has not been studied, but it is likely that high levels of maternally derived antibodies may interfere with the development of active immunity in calves. A small number of individuals may fail to respond to vaccination as a result of immunological incompetence or for some other reason. In the face of an outbreak of disease, it is therefore important to avoid vaccination of animals which have overt clinical salmonellosis or intercurrent disease or which have a poor nutritional status. Such animals must be isolated and treated as appropriate and then vaccinated upon clinical recovery. Operator warnings Not applicable. Adverse Reactions Swellings at the injection site may occur. Typically, these swellings may be warm when compared to the surrounding area for up to 5 days after vaccination, reach a maximum size within 1 - 6 days after vaccination and completely disappear or reduce to clinically insignificant reactions within 2 - 3 weeks after vaccination. In addition, swellings may be slightly painful on palpation for 1 - 2 days after vaccination, although this will not require veterinary intervention. Occasional hypersensitivity reactions may occur. If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. Use during pregnancy or lactation When vaccinating animals, stress should be avoided, particularly during pregnancy. The effect of Bovilis Bovivac S administered around service/insemination has not been studied. Limited laboratory and field data suggest that vaccination with Bovilis Bovivac S has no adverse effect on pregnancy and calving. Interactions No information is available on the safety and efficacy from the concurrent use of this vaccine with any other. It is therefore recommended that no other vaccines should be administered within 14 days before or after vaccination with this product.
Vat Rate: 20%